Search the Newsreel

Takeda Pharmaceutical (NYSE:TAK) CEO Sells $1,523,439.00 in Stock

Takeda Pharmaceutical's CEO, Julie So-Young Kim, sold 89,090 shares of company stock for over $1.5 million to cover tax obligations from vested equity awards, reducing her ownership by 18.54%. The company's stock trades at $17.42 with a market cap of $55.82 billion, and analyst …

Elaine Mary Shannon Sells 3,978 Shares of Takeda Pharmaceutical (NYSE:TAK) Stock

Cheesecake factory president sells $3.5m in stock following exercise

David M. Gordon, President of The Cheesecake Factory Inc. (NASDAQ:CAKE), sold approximately $3.52 million worth of company stock on August 10, 2026, following the exercise of employee stock options. The transactions occurred while CAKE's stock was near its 52-week high, having gained 84% over …

Precision Trading with Snowflake Inc. Class A (SNOW) Risk Zones

This article analyzes Snowflake Inc. Class A (SNOW) using AI models to identify key findings, risk zones, and trading strategies. It presents distinct strategies for different risk profiles, including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis. The report highlights …

Takeda Pharmaceutical (NYSE: TAK) executive sells 7,277 ADS in tax-related trade

Ramy Riad Ahmed, President of the PDT business unit at Takeda Pharmaceutical Co Ltd (NYSE: TAK), sold 7,277 American Depositary Shares (ADS) on August 10, 2026, at a weighted average price of $17.10 per share. This sale was mandatory to cover taxes related to …

Takeda (TAK) executive sells 25,088 ADSs in mandatory tax-related trade

Takeda Pharmaceutical Co Ltd's Chief Data & Tech. Officer, Gabriele Ricci, sold 25,088 American Depositary Shares (ADSs) on August 10, 2026, at a weighted average price of $17.10 per ADS. This transaction was a mandatory sale to cover tax obligations related to vested equity …

Insider Selling: Cheesecake Factory (NASDAQ:CAKE) Director Sells 3,000 Shares of Stock

Cheesecake Factory Director Edie Ames sold 3,000 shares of CAKE stock for $320,850, reducing her direct ownership by 23.08% to 10,000 shares. This transaction occurred on August 10th and was disclosed in an SEC filing. The sale comes as CAKE shares rose 3.7% to …

David Gordon Sells 31,950 Shares of Cheesecake Factory (NASDAQ:CAKE) Stock

Takeda Pharmaceutical (NYSE: TAK) counsel sells 30,868 ADSs to cover taxes

Takeda Pharmaceutical's Global General Counsel, Natalie Anne Marie Furney, sold 30,868 American Depositary Shares (ADSs) on August 10, 2026, for a weighted average price of $17.10 per ADS. This transaction was a mandatory sale to cover tax obligations related to the vesting of equity …

Why Quaker Chemical (KWR) Is Getting Attention Today

Quaker Chemical (KWR) is gaining attention due to strong Q2 2026 results, showing increased sales and a return to profit, alongside positive analyst commentary. Despite a 14.12% 30-day share price return and 21.53% year-to-date, its 5-year performance is down 25.62%, indicating a recent recovery. …

Unity Software Stock Rebounds as Revenue Hits $508M [2026]

Unity Software reported strong Q1 2026 results, with revenue reaching $508.2 million, a 16.8% increase year-over-year, signaling a recovery after its 2023 Runtime Fee crisis. The company's guidance for Q2 2026 indicates continued double-digit growth, reinforcing investor confidence. This rebound is attributed to improved …

Cheesecake Factory (CAKE) director reports 3,000-share sale and past purchase fix

Cheesecake Factory director Edie A. Ames reported insider activity, with a trust associated with her selling 3,000 shares of common stock at $106.95 per share on August 10, 2026. The filing also corrected a previously omitted purchase of 500 shares at $49.51 per share …

Westlake Chemical Partners LP Common Units (WLKP) Presents at Citi's 2026 Natural Resources Conference - Slideshow (NYSE:WLKP) 2026-08-12

Lakefront Biotherapeutics (LKFT) repurchases 103,970 shares in €2.41M buyback tranche

Lakefront Biotherapeutics (LKFT) announced the repurchase of 103,970 ordinary shares between August 3 and August 7, 2026, for a total of €2,409,901.40. The shares were bought at an average price of €23.18 each, as part of a program initiated on June 9, 2026. Following …

Cushman & Wakefield: AI Infrastructure Boom Fuels Growing Wave of Industrial Demand Beyond the Data Center

Data center-related companies accounted for a record 14.4% of industrial leasing across six major U.S. markets in 2025, up 44% from the prior year NEW YORK, August 12, 2026--(BUSINESS WIRE)--As investment in AI infrastructure accelerates, the conversation around data centers has largely focused on …

Oppenheimer Revamps Snowflake Stock Target For 2026

This article first appeared on GuruFocus. Snowflake (NYSE:SNOW) is drawing a much more bullish view from Oppenheimer, which raised its price target to $400 from $295 as stronger consumption trends and accelerating adoption of AI coding agent CoCo point to faster growth ahead. The …

Monro, Inc. (MNRO) director receives 11,149-share restricted stock grant

Monro, Inc. director Thomas B. Okray was granted 11,149 shares of restricted common stock on August 11, 2026, under the company's Amended and Restated 2007 Stock Incentive Plan. This award, which has no cash purchase price, increases his direct holdings to 24,392 shares. The …

What Does Baker Hughes (BKR) Winning A Kuwait Tech Contract Mean?

Shake Shack (SHAK) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Head of Investor Relations - Alison SternbergChief Executive Officer - Robert LynchChief Financial Officer - Michelle Hook TAKEAWAYS Total Revenue -- $417.6 million, an increase of 17.2% year …

Acquisition of Own Shares

Lakefront Biotherapeutics NV announced the repurchase of 103,970 of its own shares between August 3 and August 7, 2026, as part of a previously announced repurchase program. The shares were acquired via a discretionary mandate to an independent financial intermediary, with a total value …

Why Lakeland Financial (LKFN) is a Great Dividend Stock Right Now

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments. Cash flow …

Adage Capital discloses 3.18% Monro, Inc. (MNRO) ownership in updated 13G filing

Adage Capital Management, L.P., along with Robert Atchinson and Phillip Gross, has reported a beneficial ownership of 3.18% in Monro, Inc. (MNRO) through an updated 13G filing. This represents 995,201 shares of common stock, based on 31,246,875 shares outstanding as of June 22, 2026. …

Why Take-Two Interactive Software (TTWO) Stock Is Down Today

J.P. Morgan Initiates Take-Two Interactive Software(TTWO.US) With Buy Rating, Announces Target Price $310

J.P. Morgan has initiated coverage on Take-Two Interactive Software (TTWO.US) with a "Buy" rating. The firm has set a price target of $310 for the video game publisher. This rating suggests J.P. Morgan's positive outlook on the company's stock performance.

Lakefront Biotherapeutics (LKFT) swings to H1 2026 profit and tightens cash outlook

Lakefront Biotherapeutics (LKFT) reported a net profit of €16.6 million for the first half of 2026, a significant turnaround from a €259.1 million net loss in H1 2025, primarily due to reduced operating losses and substantial net financial income. The company completed the acquisition …

Cushman & Wakefield (CWK) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Head of Investor Relations - Megan McGrath Chief Executive Officer - Michelle MacKay Chief Financial Officer - Neil Johnston Full Conference Call Transcript Operator: Good day, everyone, and …

Westlake Corp (WLK) chair Albert Chao exercises 38,873 options and sells shares

Westlake Corp Executive Chairman Albert Chao exercised 38,873 employee stock options at $61.865 per share and subsequently sold all 38,873 resulting common shares in open-market transactions on August 11, 2026. The shares were sold in two blocks at weighted average prices of $79.70 and …

Zacks Research Issues Optimistic Forecast for CAKE Earnings

5 Insightful Analyst Questions From Cushman & Wakefield’s Q2 Earnings Call

5 Insightful Analyst Questions From Cushman & Wakefield's Q2 Earnings Call Cushman & Wakefield delivered a Q2 result that met Wall Street's earnings expectations and exceeded consensus revenue forecasts. Management attributed performance to broad-based growth across its global platform, with notable strength in leasing—especially …

MoonLake’s Psoriatic Arthritis Drug Shows Promise In Late-Stage Study

MoonLake Immunotherapeutics announced positive Week 16 topline results from its Phase 3 IZAR-1 trial for sonelokimab in biologic-naïve adults with active psoriatic arthritis, meeting all primary and secondary clinical endpoints. Despite the positive results, the stock fell over 6%. The company also reported strong …

Yellow Cake Expands Uranium Holdings With $100 Million Kazatomprom Delivery

Baker Hughes Co (BKR) Gewinnprognose: Zukünftige EPS & Umsatzwachstumsprognosen

Lakeland Financial Corp (LKFN) Earnings Forecast: Future EPS & Revenue Growth Estimates

Takeda Pharmaceutical (TSE:4502) Is Using AI To Advance Three Late Stage Medicines

Yellow Cake boosts uranium stockpile with $100m Kazatomprom delivery

Monro, Inc. (MNRO) options chain

This article provides the options chain for Monro, Inc. (MNRO) as of August 12, 2026, including both call and put options with an expiration date of January 15, 2027. It lists various strike prices, last trade dates, last prices, and other option details, noting …